12/18/18
Alkermes Plc ALKS and partner Biogen BIIB announced that they have submitted a new drug application NDA to the FDA for diroximel fumarate BIIB098 a novel oral fumarate being developed for the treatment of relapsing forms of multiple sclerosis MS 160 The NDA submission was
12/18/18
Teva Pharmaceutical Industries Ltd TEVA announced positive top line results from the phase IIIb FOCUS study 160 that evaluated the efficacy and safety of fremanezumab for the preventive treatment of migraine in adult patients who previously experienced inadequate responses to two to
12/18/18
It s been a wild year for the stock market after what was an almost too quiet 2017 Having made it through the previous year without so much as a decline beyond 4 the markets major indexes have undergone two full blown corrections in 2018 And by correction I mean a decline of at
12/17/18
Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares MSCI EAFE ETF Symbol EFA where we have detected an approximate 181 3 million dollar inflow that s a 0 3 increase week over week in outstanding
12/17/18
Teva Reports Positive Topline Phase IIIb Results With Fremanezumab - Quick Facts
12/17/18
Teva Reports Positive Topline Phase IIIb Results With Fremanezumab - Quick Facts
12/13/18
InvestorPlace Stock Market News Stock Advice amp Trading Tips The last few years for drug maker Teva Pharmaceuticals NASDAQ TEVA haven t exactly been that wonderful TEVA stock has plunged on a series of mishaps and issues In fact TEVA has fallen
12/11/18
What happened Shares of Corcept Therapeutics NASDAQ CORT were up 18 6 in November according to data provided by S amp P Global Market Intelligence after the biotech released promising third quarter earnings results 160 and made progress on its second generation Cushing
12/11/18
Shares of Teva Pharmaceutical Industries Limited TEVA have picked up pace this year so far after declining sharply in 2017 Though the stock has declined 2 7 this year it has outperformed its industry s decline of 14 Last year Teva s stock declined a massive 54
12/11/18
MYOS Muscling Up, CORT Turns Heads, Former FDA Official Joins PTE Board
12/11/18
MYOS Muscling Up, CORT Turns Heads, Former FDA Official Joins PTE Board
12/11/18
InvestorPlace Stock Market News Stock Advice amp Trading Tips For the better part of Monday stocks were in the red Once push came to shove as the closing bell approached though yesterday s move to new multi months lows was negated The S amp P 500 finished at 2637 72
12/11/18
Shares of generic drugmakers took a hit on Monday after allegations related to price fixing of several drugs surfaced in an article published on The Washington Post Shares of all major players in the generic industry plunged following the report Shares of Mylan MYL fell 0 8
12/10/18
Wall Street went through another session of extreme volatility on Monday Having fallen nearly 2 at earlier points in the day the broad based S amp P 500 index finished fairly close to unchanged with key sectors like technology helping to provide support to the overall market
12/10/18
The NASDAQ 100 After Hours Indicator is up 8 76 to 6 691 5 The total After hours volume is currently 62 253 799 shares traded The following are the most active stocks for the after hours session Visa Inc V is 0 44 at 138 32 with 5 993 303 shares traded As
12/10/18
Legendary investor Warren Buffett advises to be fearful when others are greedy and be greedy when others are fearful One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index or RSI which measures momentum on
12/07/18
Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares MSCI ACWI ex U S ETF Symbol ACWX where we have detected an approximate 328 7 million dollar inflow that s a 9 8 increase week over week in
12/06/18
Roche RHHBY announced that its breast cancer drug Kadcyla significantly reduced the risk of disease recurrence by 50 as adjuvant after surgery therapy in phase III KATHERINE study compared to its other breast cancer drug Herceptin The late stage KATHERINE study compared Kadcyla to
12/05/18
Mylan N V MYL expanded its voluntary recall of blood pressure medicine Valsartan based products in the United States to include all lots of Valsartan containing products which have not expired Late last month the company had announced a recall of selected lots The company is
TEVA - Teva Pharmaceutical Industries Limited